{"id":"https://openalex.org/W2396526272","doi":"https://doi.org/10.18632/oncotarget.9499","title":"Pre-clinical efficacy and synergistic potential of the MDM2-p53 antagonists, Nutlin-3 and RG7388, as single agents and in combined treatment with cisplatin in ovarian cancer","display_name":"Pre-clinical efficacy and synergistic potential of the MDM2-p53 antagonists, Nutlin-3 and RG7388, as single agents and in combined treatment with cisplatin in ovarian cancer","alternate_titles":[],"publication_year":2016,"publication_date":"2016-05-20","ids":{"openalex":"https://openalex.org/W2396526272","doi":"https://doi.org/10.18632/oncotarget.9499","mag":"2396526272","pmid":"https://pubmed.ncbi.nlm.nih.gov/27223080","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5129997"},"language":"en","primary_location":{"id":"doi:10.18632/oncotarget.9499","doi":"https://doi.org/10.18632/oncotarget.9499","is_oa":true,"landing_page_url":"https://doi.org/10.18632/oncotarget.9499","pdf_url":"http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=9499&path%5B%5D=29607","source":{"id":"https://openalex.org/S126644158","display_name":"Oncotarget","issn_l":"1949-2553","issn":["1949-2553"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","medline","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316297","host_organization_name":"Impact Journals LLC","host_organization_lineage":["https://openalex.org/P4310316297"],"host_organization_lineage_names":["Impact Journals LLC"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2396526272"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=9499&path%5B%5D=29607","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021362343","display_name":"Maryam Zanjirband","orcid":"https://orcid.org/0000-0002-5946-0998","observed_orcids":["https://orcid.org/0000-0002-5946-0998"]},"institutions":[{"id":"https://openalex.org/I84884186","display_name":"Newcastle University","ror":"https://ror.org/01kj2bm70","country_code":"GB","type":"education","lineage":["https://openalex.org/I84884186"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Maryam Zanjirband","raw_affiliation_strings":["Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne NE2 4HH, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne NE2 4HH, United Kingdom","institution_ids":["https://openalex.org/I84884186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038850730","display_name":"Richard John Edmondson","orcid":"https://orcid.org/0000-0003-2553-4423","observed_orcids":["https://orcid.org/0000-0003-2553-4423"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Richard J. Edmondson","raw_affiliation_strings":["Faculty Institute for Cancer Sciences, University of Manchester, Manchester M13 9WL, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty Institute for Cancer Sciences, University of Manchester, Manchester M13 9WL, United Kingdom","institution_ids":["https://openalex.org/I28407311"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5005245931","display_name":"John Lunec","orcid":"https://orcid.org/0000-0002-1878-8583","observed_orcids":["https://orcid.org/0000-0002-1878-8583"]},"institutions":[{"id":"https://openalex.org/I84884186","display_name":"Newcastle University","ror":"https://ror.org/01kj2bm70","country_code":"GB","type":"education","lineage":["https://openalex.org/I84884186"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"John Lunec","raw_affiliation_strings":["Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne NE2 4HH, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne NE2 4HH, United Kingdom","institution_ids":["https://openalex.org/I84884186"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5005245931"],"corresponding_institution_ids":["https://openalex.org/I84884186"],"apc_list":null,"apc_paid":{"value":3099,"currency":"EUR","value_usd":3342},"fwci":4.4622,"has_fulltext":true,"cited_by_count":68,"citation_normalized_percentile":{"value":0.96129071,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":91,"max":99},"biblio":{"volume":"7","issue":"26","first_page":"40115","last_page":"40134"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.00430000014603138,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.9829999804496765},{"id":"https://openalex.org/keywords/mdm2-p53-antagonist","display_name":"MDM2-p53 antagonist","score":0.9700000286102295},{"id":"https://openalex.org/keywords/nutlin-3","display_name":"Nutlin-3","score":0.9959999918937683},{"id":"https://openalex.org/keywords/rg7388","display_name":"RG7388","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.8840000033378601},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7519999742507935},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.6079999804496765},{"id":"https://openalex.org/keywords/p53-activation","display_name":"p53 activation","score":0.9599999785423279},{"id":"https://openalex.org/keywords/p21","display_name":"p21","score":0.8349999785423279},{"id":"https://openalex.org/keywords/caspase-3-7","display_name":"caspase 3/7","score":0.8389999866485596},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.9169999957084656},{"id":"https://openalex.org/keywords/cell-cycle-arrest","display_name":"cell cycle arrest","score":0.9819999933242798},{"id":"https://openalex.org/keywords/dna-repair-genes","display_name":"DNA repair genes","score":0.7559999823570251},{"id":"https://openalex.org/keywords/tp53-mutation","display_name":"TP53 mutation","score":0.7730000019073486},{"id":"https://openalex.org/keywords/mdm2-inhibition","display_name":"MDM2 inhibition","score":0.5730000138282776}],"concepts":[{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.7425066828727722},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.6580988764762878},{"id":"https://openalex.org/C2776192174","wikidata":"https://www.wikidata.org/wiki/Q18028978","display_name":"Mdm2","level":3,"score":0.5665085315704346},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5605059266090393},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5557079315185547},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.5482245087623596},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5434910655021667},{"id":"https://openalex.org/C2779707156","wikidata":"https://www.wikidata.org/wiki/Q5611758","display_name":"Growth inhibition","level":3,"score":0.4289557933807373},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3979032337665558},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.38774603605270386},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.35882115364074707},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2983999252319336},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.25847914814949036},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D002453","descriptor_name":"Cell Cycle","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004260","descriptor_name":"DNA Repair","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005838","descriptor_name":"Genotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011759","descriptor_name":"Pyrrolidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015972","descriptor_name":"Gene Expression Regulation, Neoplastic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016159","descriptor_name":"Tumor Suppressor Protein p53","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051736","descriptor_name":"Proto-Oncogene Proteins c-mdm2","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D062366","descriptor_name":"para-Aminobenzoates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.18632/oncotarget.9499","doi":"https://doi.org/10.18632/oncotarget.9499","is_oa":true,"landing_page_url":"https://doi.org/10.18632/oncotarget.9499","pdf_url":"http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=9499&path%5B%5D=29607","source":{"id":"https://openalex.org/S126644158","display_name":"Oncotarget","issn_l":"1949-2553","issn":["1949-2553"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","medline","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316297","host_organization_name":"Impact Journals LLC","host_organization_lineage":["https://openalex.org/P4310316297"],"host_organization_lineage_names":["Impact Journals LLC"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:4088072","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5129997","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:5129997","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5129997/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"Text"},{"id":"pmid:27223080","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27223080","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"Journal Article"},{"id":"pmh:oai:pure.atira.dk:openaire/4060d024-6973-4614-bcd2-7e45c11c4dd9","doi":null,"is_oa":true,"landing_page_url":"https://www.scopus.com/pages/publications/84982969232","pdf_url":null,"source":{"id":"https://openalex.org/S4306400662","display_name":"Research Explorer (The University of Manchester)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I28407311","host_organization_name":"University of Manchester","host_organization_lineage":["https://openalex.org/I28407311"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Edmondson, R, Lunec, J & Zanjirband, M 2016, 'Pre-clinical efficacy and synergistic potential of the MDM2-p53 antagonists, Nutlin-3 and RG7388, as single agents and in combined treatment with cisplatin in ovarian cancer', Oncotarget. https://doi.org/10.18632/oncotarget.9499","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.18632/oncotarget.9499","doi":"https://doi.org/10.18632/oncotarget.9499","is_oa":true,"landing_page_url":"https://doi.org/10.18632/oncotarget.9499","pdf_url":"http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=9499&path%5B%5D=29607","source":{"id":"https://openalex.org/S126644158","display_name":"Oncotarget","issn_l":"1949-2553","issn":["1949-2553"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","medline","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316297","host_organization_name":"Impact Journals LLC","host_organization_lineage":["https://openalex.org/P4310316297"],"host_organization_lineage_names":["Impact Journals LLC"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.979200005531311,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2719936101","display_name":null,"funder_award_id":"C0190R4011","funder_id":"https://openalex.org/F4320320295","funder_display_name":"Newcastle University"}],"funders":[{"id":"https://openalex.org/F4320319985","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67"},{"id":"https://openalex.org/F4320320295","display_name":"Newcastle University","ror":"https://ror.org/01kj2bm70"},{"id":"https://openalex.org/F4320320987","display_name":"Curtin University of Technology","ror":"https://ror.org/02n415q13"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2396526272.pdf","grobid_xml":"https://content.openalex.org/works/W2396526272.grobid-xml"},"referenced_works_count":45,"referenced_works":["https://openalex.org/W1487044430","https://openalex.org/W1895234166","https://openalex.org/W1960438017","https://openalex.org/W1964304371","https://openalex.org/W1972618720","https://openalex.org/W1976295398","https://openalex.org/W1978259246","https://openalex.org/W1985683054","https://openalex.org/W1990054550","https://openalex.org/W1991167758","https://openalex.org/W2003003988","https://openalex.org/W2008848392","https://openalex.org/W2009427067","https://openalex.org/W2014954354","https://openalex.org/W2023940736","https://openalex.org/W2024508589","https://openalex.org/W2028282498","https://openalex.org/W2028387032","https://openalex.org/W2036793911","https://openalex.org/W2044085417","https://openalex.org/W2052516738","https://openalex.org/W2052661605","https://openalex.org/W2077902171","https://openalex.org/W2088996957","https://openalex.org/W2090968329","https://openalex.org/W2096439168","https://openalex.org/W2098748257","https://openalex.org/W2101019828","https://openalex.org/W2103562758","https://openalex.org/W2103616303","https://openalex.org/W2113370608","https://openalex.org/W2115954319","https://openalex.org/W2127587768","https://openalex.org/W2143405385","https://openalex.org/W2150844813","https://openalex.org/W2151439322","https://openalex.org/W2154041044","https://openalex.org/W2162262059","https://openalex.org/W2162460329","https://openalex.org/W2162645859","https://openalex.org/W2170580929","https://openalex.org/W2184915239","https://openalex.org/W2214184280","https://openalex.org/W2781580654","https://openalex.org/W4237115449"],"related_works":["https://openalex.org/W7221167239","https://openalex.org/W3093227561","https://openalex.org/W2734365258","https://openalex.org/W2052661605","https://openalex.org/W7009484547","https://openalex.org/W2162795905","https://openalex.org/W2592386166","https://openalex.org/W2053083744","https://openalex.org/W1960438017","https://openalex.org/W4409690648"],"abstract_inverted_index":{"//":[0],"Maryam":[1],"Zanjirband":[2],"1":[3,12,13],",":[4,9],"Richard":[5],"J.":[6],"Edmondson":[7],"2":[8,28],"John":[10,44],"Lunec":[11],"Northern":[14],"Institute":[15,30],"for":[16,31,105,261],"Cancer":[17,32],"Research,":[18],"Newcastle":[19,21],"University,":[20],"upon":[22],"Tyne":[23],"NE2":[24],"4HH,":[25],"United":[26,40],"Kingdom":[27,41],"Faculty":[29],"Sciences,":[33],"University":[34],"of":[35,77,100,107,117,124,135,147,164,179,231,242,264],"Manchester,":[36],"Manchester":[37],"M13":[38],"9WL,":[39],"Correspondence":[42],"to:":[43],"Lunec,":[45],"email:":[46],"john.lunec@ncl.ac.uk":[47],"Keywords:":[48],"ovarian":[49,180,265],"cancer,":[50,266],"MDM2-p53":[51,126],"antagonists,":[52],"Nutlin-3/RG7388,":[53],"p53,":[54],"combined":[55],"treatment":[56,252,263],"Received:":[57],"March":[58],"22,":[59],"2016":[60,64,68],"Accepted:":[61],"April":[62],"26,":[63],"Published:":[65],"May":[66],"20,":[67],"ABSTRACT":[69],"Ovarian":[70],"cancer":[71,181],"is":[72,129],"the":[73,101,112,125,140,145,162,229,236,245,262],"fifth":[74],"leading":[75,143],"cause":[76],"cancer-related":[78],"female":[79],"deaths.":[80],"Due":[81],"to":[82,89,144,222],"serious":[83],"side":[84],"effects,":[85],"relapse":[86],"and":[87,93,149,166,171,210,239,256],"resistance":[88],"standard":[90],"chemotherapy,":[91],"better":[92],"more":[94],"targeted":[95],"approaches":[96],"are":[97],"required.":[98],"Mutation":[99],"TP53":[102],"gene":[103],"accounts":[104],"50%":[106],"all":[108],"human":[109],"cancers.":[110],"In":[111],"remaining":[113],"malignancies,":[114],"non-genotoxic":[115],"activation":[116],"wild-type":[118],"p53":[119,205,243],"by":[120],"small":[121],"molecule":[122],"inhibition":[123,227],"binding":[127],"interaction":[128],"a":[130,177,199],"promising":[131],"therapeutic":[132],"strategy.":[133],"Proof":[134],"concept":[136],"was":[137,193],"established":[138],"with":[139,174,191,213,253],"cis-imidazoline":[141],"Nutlin-3,":[142],"development":[146],"RG7388":[148,167,189],"other":[150],"compounds":[151],"currently":[152],"in":[153,172,176,198,203],"early":[154],"phase":[155],"clinical":[156],"trials.":[157],"This":[158],"preclinical":[159],"study":[160],"evaluated":[161],"effect":[163],"Nutlin-3":[165,187],"as":[168],"single":[169],"agents":[170],"combination":[173,190,251],"cisplatin":[175,192,223,257],"panel":[178],"cell":[182,207,269],"lines.":[183],"Median-drug-effect":[184],"analysis":[185],"showed":[186],"or":[188,196],"additive":[194],"to,":[195],"synergistic":[197,259],"p53-dependent":[200,232],"manner,":[201],"resulting":[202],"increased":[204,214],"activation,":[206],"cycle":[208],"arrest":[209],"apoptosis,":[211],"associated":[212],"p21":[215],"WAF1":[216],"protein":[217],"and/or":[218],"caspase-3/7":[219],"activity":[220],"compared":[221],"alone.":[224],"Although":[225],"MDM2":[226,254],"activated":[228],"expression":[230],"DNA":[233],"repair":[234],"genes,":[235],"growth":[237],"inhibitory":[238],"pro-apoptotic":[240],"effects":[241],"dominated":[244],"response.":[246],"These":[247],"data":[248],"indicate":[249],"that":[250],"inhibitors":[255],"has":[258],"potential":[260],"dependent":[267],"on":[268],"genotype.":[270]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2396526272","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":12},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":5}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
